Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 434,219 | 9,017 | 0 | N/A | N/A |
| Receivables | N/A | 536 | 0 | N/A | N/A |
| TOTAL | $435,992 | $9,809 | $0 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 52 | 860 | 0 | N/A | N/A |
| Other Non-Current Assets | 10 | 7 | 0 | 0 | 0 |
| TOTAL | $62 | $867 | $N/A | $N/A | $N/A |
| Total Assets | $436,054 | $10,676 | $0 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 76 | 3,748 | 0 | 0 | 0 |
| Accrued Expenses | 6,128 | 1,236 | 0 | N/A | N/A |
| TOTAL | $6,204 | $4,984 | $0 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 5,421 | 0 | N/A | N/A |
| Other Non-Current Liabilities | 5 | 70,910 | 0 | 0 | 0 |
| TOTAL | $5 | $76,331 | $N/A | $N/A | $N/A |
| Total Liabilities | $6,209 | $81,315 | $0 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,127 | N/A | N/A | N/A | N/A |
| Common Shares | 40 | 3 | 0 | N/A | N/A |
| Retained earnings | -118,522 | -72,782 | 0 | N/A | N/A |
| TOTAL | $429,845 | $-70,639 | $0 | $N/A | $N/A |
| Total Liabilities And Equity | $436,054 | $10,676 | $0 | $0 | $0 |